story of the week
Association of Immunophenotype With pCR to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial
JAMA Oncol 2021 Feb 18;[EPub Ahead of Print], OM Filho, DG Stover, S Asad, PJ Ansell, M Watson, S Loibl, CE Geyer, J Bae, K Collier, M Cherian, J O'Shaughnessy, M Untch, HS Rugo, JB Huober, M Golshan, WM Sikov, G von Minckwitz, P Rastogi, D Maag, N Wolmark, C Denkert, WF SymmansFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.